Page last updated: 2024-08-23

silybin and Recrudescence

silybin has been researched along with Recrudescence in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alfonso-Moreno, V; López-Serrano, A; Moreno-Osset, E1
Bander, D; Jurczyk, K; Karpińska, E; Lachtara, M; Laurans, Ł; Socha, Ł; Wawrzynowicz-Syczewska, M1
Galle, PR; Knapstein, J; Wörns, MA; Zimmermann, T1
Meissner, EG1
Bahra, M; Berg, T; Biermer, M; Boas-Knoop, S; Eurich, D; Neuhaus, P; Neuhaus, R; Neumann, U1
Beinhardt, S; Ferenci, P; Hofer, H; Kerschner, H; Popow-Kraupp, T; Rutter, K; Scherzer, TM; Stättermayer, AF; Steindl-Munda, P1

Other Studies

6 other study(ies) available for silybin and Recrudescence

ArticleYear
Chemoprevention of polyp recurrence with curcumin followed by silibinin in a case of multiple colorectal adenomas.
    Revista espanola de enfermedades digestivas, 2017, Volume: 109, Issue:12

    Topics: Antineoplastic Agents; Chemoprevention; Colorectal Neoplasms; Curcumin; Drug Therapy, Combination; Humans; Intestinal Polyps; Male; Middle Aged; Recurrence; Silybin; Silymarin

2017
Rescue therapy with intravenous silibinin in liver transplant recipients with recurrent HCV hepatitis - two case reports.
    Annals of transplantation, 2014, Apr-08, Volume: 19

    Topics: Administration, Intravenous; Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis C, Chronic; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recurrence; Salvage Therapy; Silybin; Silymarin

2014
Combination therapy with silibinin, pegylated interferon and ribavirin in a patient with hepatitis C virus genotype 3 reinfection after liver transplantation: a case report.
    Journal of medical case reports, 2014, Jul-21, Volume: 8

    Topics: Antiviral Agents; Drug Therapy, Combination; Genotype; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon-alpha; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; Silybin; Silymarin

2014
Continued value in understanding viral kinetic decline during interferon-free therapy for HCV.
    Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:2

    Topics: Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Recurrence; RNA, Viral; Silybin; Silymarin; Virus Replication

2015
Treatment of hepatitis C-virus-reinfection after liver transplant with silibinin in nonresponders to pegylated interferon-based therapy.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2011, Volume: 9, Issue:1

    Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Biomarkers; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Infusions, Intravenous; Interferon alpha-2; Interferon-alpha; Liver Failure; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral; Silybin; Silymarin; Time Factors; Treatment Failure; Viral Load

2011
Intravenous silibinin as 'rescue treatment' for on-treatment non-responders to pegylated interferon/ribavirin combination therapy.
    Antiviral therapy, 2011, Volume: 16, Issue:8

    Topics: Adult; Antioxidants; Antiviral Agents; Austria; Cohort Studies; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Injections, Intravenous; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral; Silybin; Silymarin; Treatment Outcome; Viral Load; Virus Replication

2011